AstraZeneca Wins Pause on Utah Contract Pharmacy Law Enforcement - news.bloomberglaw.com
AstraZeneca obtained a court-ordered pause on enforcement of Utah's contract pharmacy law, temporarily blocking the state from requiring drugmakers to supply 340B-priced drugs to contract pharmacies.
Aforeworn detected this change in the Pharmaceutical Manufacturing (FDA/DEA) space on July 30, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Branded drug manufacturers (especially those with 340B pricing obligations) and contract pharmacies operating in Utah. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified; the pause is in effect until further court order.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmaceutical Manufacturing (FDA/DEA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
A federal court temporarily halted enforcement of Utah's contract pharmacy law, which had required manufacturers to distribute 340B-discounted drugs to contract pharmacies. The pause means manufacturers are not currently required to comply with that state law.
Who it affects
Branded drug manufacturers (especially those with 340B pricing obligations) and contract pharmacies operating in Utah.
What you must do
No immediate action required; monitor the court case for final ruling or further orders.
Deadline
Not specified; the pause is in effect until further court order.
Never miss a change like this again
Aforeworn watches Pharmaceutical Manufacturing (FDA/DEA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmaceutical Manufacturing (FDA/DEA)
- US-CONGRESS BILLS-119hr9693ih: Patients First Act of 2026
- FDA Allowing Florida to Import Cheaper Drugs from Canada - supplychainbrain.com
- “Hub-and-spoke” drug manufacturing set to benefit from new FDA rule - pharmaceutical-technology.com
- Judge refuses to block sending abortion pill by mail for now, but says FDA must finish review - statnews.com
- The FDA no longer requires all drugs to be tested on animals before human trials - opb.org